ClinicalTrials.Veeva

Menu

Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term

H

Hospital de Santa Maria, Portugal

Status and phase

Completed
Phase 3
Phase 2

Conditions

Chorioamnionitis
Puerperal Endometritis
Neonatal Meningitis
Neonatal Pneumonia
Neonatal Early Onset Sepsis

Treatments

Drug: Ampicillin + gentamicin

Study type

Interventional

Funder types

Other

Identifiers

NCT01633294
335/08 - 28/07/08

Details and patient eligibility

About

The aims of this study are to determine whether antibiotics administered routinely in women presenting with premature rupture of membranes later than the 37+0 weeks of gestation can alter the rate of maternal and neonatal infection and to compare these rates between prompt (< 12 hour) and delayed (≥ 12 hour) induction in the group of patients not submitted to antibiotic prophylaxis.

Enrollment

161 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • term (≥ 37+0 weeks) singleton pregnancy
  • a vertex presentation
  • ruptured membranes for less than 12 hours
  • negative Group B Streptococcus (GBS) culture performed between 35 and 37 weeks

Exclusion criteria

  • active labor
  • absence of GBS culture or indication for GBS antibiotic prophylaxis (such as maternal GBS colonization between 35 and 37 weeks, GBS bacteriuria, prior infant with GBS sepsis)
  • contraindication to expectant management (such as fetal distress, meconium staining of the amniotic fluid or chorioamnionitis) or to vaginal delivery

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

161 participants in 2 patient groups

Antibiotic group
Active Comparator group
Description:
women submitted to antibiotic prophylaxis
Treatment:
Drug: Ampicillin + gentamicin
Control group
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems